plaque psoriasis

Ventyx Halts TYK2 Inhibitor Following Phase 2 Success

Ventyx Halts TYK2 Inhibitor Despite Phase 2 Success, Stock Plummets 70%

Anika Sharma

Ventyx Biosciences discovered that even a seemingly successful clinical trial may not be enough to support a drug’s advancement, as ...

Zilbrysq: UCB’s new antibody for myasthenia gravis

Zilbrysq, A Complement C5 Inhibitor For Myasthenia Gravis, Gets FDA Approval As UCB’s Second Drug For The Rare Disease

Anika Sharma

UCB is celebrating an impressive streak of FDA approvals, securing the green light for both the plaque psoriasis treatment Bimzelx ...